Why is Remedium Life falling/rising?

As of 10-Sep, Remedium Lifecare Ltd's stock price is currently at 1.48, reflecting an increase of 0.04 or 2.78%. The stock has shown strong performance in the short term, with a 15.62% increase over the past week and a 22.31% rise over the past month, significantly outperforming the Sensex, which only increased by 1.06% and 1.96% in the same periods, respectively. Today's trading volume indicates rising investor participation, with a delivery volume of 70.45 lacs, up 17.61% compared to the five-day average. However, the company faces significant challenges, including a high Debt to EBITDA ratio of -1.00 times, negative returns on capital employed, and a drastic decline in net sales by 76.36%, which has led to negative results for four consecutive quarters.
Broader market context shows that while Remedium Lifecare has outperformed the benchmark in the short term, it has significantly underperformed over the longer term, with a year-to-date decline of 58.59% compared to a 4.21% increase in the Sensex. The stock's long-term growth prospects appear poor, with an annual operating profit decline of 303.30% over the last five years, indicating a risky investment compared to its historical valuations. Despite the recent uptick in price, the overall financial health of the company raises concerns about its sustainability and ability to recover in the long run.